LYTIR

Company · APMD

Apnimed, Inc.

Nasdaq's symbol directory lists APMD on Nasdaq as “Apnimed, Inc. - Common Stock”.

In the 12 months to Nov 19, 2026: insiders bought on 2 occasions ($5.2M); 4 filings by holders of 5% or more; 2 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Morningside Venture Investments Ltd bought on 1 day latest Aug 3, 2026 bought $5.0M
  2. SEKHRI PAUL J bought on 1 day latest Aug 3, 2026 bought $200K
Every trade (2)
  1. BUYMorningside Venture Investments Ltd bought Aug 3, 2026 312,500 shares filing $5.0M
  2. BUYSEKHRI PAUL J bought Aug 3, 2026 12,500 shares filing $200K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Miller Lawrence G. filed Nov 16, 2026 Schedule 13G passive filing 6.2%
  2. SHIONOGI & CO LTD filed Nov 4, 2026 Schedule 13G passive filing 7.1%
  3. Ameriprise Financial, Inc. filed Aug 7, 2026 Schedule 13G passive filing 18.9%
  4. Tao Capital Management LP filed Aug 6, 2026 Schedule 13G passive 2,178,138 shares filing 5.2%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition filing Nov 16, 2026
  2. Non-reliance on previously issued financial statements filing Nov 13, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.